IDTechEx showcases why Boston is at heart of 3D printing revolution
3D printing is rapidly reaching industrial commercialisation in numerous sectors; IDTechEx forecast that the total market will be worth $22bn by 2028. A new 3D Printing commercial insight forum is being hosted at the Autodesk facilities in Boston, USA, May 8-9 2019. This event provides expert led sessions giving technical analysis, commercial understanding and market outlooks across key topic areas. Each session will be conducted by an IDTechEx analyst and include a high-profile industrial speaker to give their key findings and opinions.
Toyota highlight the significance of 3D printing in lightweight design
3D printing is rapidly reaching industrial commercialisation in numerous sectors; IDTechEx forecast that the total market will be worth $22bn by 2028. One of the key features is the design freedom this technology enables where, alongside other functional advantages, a major opportunity is in lightweighting.
The coming of age of 3D bioprinting?
Though activities in 3D bioprinting have been growing in leaps and bounds since 2015, the activity we have seen in 2018 has been truly remarkable for this fledgling field. Finally, governments, academic institutions and companies alike are beginning to understand the value that 3D bioprinting can bring and are working hard together to bring disruptive change through building tissues from scratch.
Demonstration of CellInk's new BioX bioprinter
Dr Nadia Tsao, an IDTechEx Analyst met with a representative of CellInk to discuss their developments in the bioprinting sector, specifically their BioX bioprinter.
IDTechEx analyst Nadia Tsao spoke with Cellink CEO Erick Gatenholm and Cellink Head of Global Sales Johan Berthag at TERMIS WC 2018.
Crocodile cartilage, human stem cells for 3D printed joint cartilage
A microbiologist in central Queensland is using 3D printing, human stem cells, and crocodile cartilage to find a new way to treat arthritis and joint injuries.
Update from the IDTechEx Show! Europe 2018
3D bioprinting - from science fiction to reality?
After over 15 years of research and development in academia and industry, several main applications of 3D bioprinting technology are ready to be realised.
IDTechEx analyst Nadia Tsao interviewed Cellink CEO Erik Gatenholm on April 20, 2017. The company focuses on developing a range of bioinks for 3D bioprinting, and also manufactures several 3D bioprinters.